The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Open accessAbstract
Cancer at single-cell resolution: Single-cell sequencing can illuminate the genetic properties of brain cancers and reveal heterogeneity within a tumor. Patel et al. examined the genome sequence of single cells isolated from brain glioblastomas. The findings revealed shared chromosomal changes but also extensive transcription variation, including genes related to signaling, which represent potential therapeutic targets. The authors suggest that the variation in tumor cells reflects neural development and that such variation among cancer cells may prove to have clinical significance. Science , this issue p. 1396
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Almost all previous work quantifying differences between single-cell datasets relies on discrete partitioning of the data before downstream analysis9–16.”
From Quantifying the effect of experimental perturbations at single-cell resolution (2021) · cites this paper as [9]
In the citing paper
“Recent studies have successfully applied similar approaches to single-cell data, for example, by Patel et al. [36] to identify gene signatures and TFs that correlate with the stemness gradient in glioblastoma”
From Mapping gene regulatory networks from single-cell omics data (2018) · cites this paper as [36]
In the citing paper
“First, in contexts such as development and physiology, some facets of cellular identity are transient in time and space. Temporal processes may, for example, progress along one or more trajectories (e.g., differentiation); oscillate continuously between cellular states (e.g., the cell cycle98,99 or circadian rhythm100); or be influenced by the physical position and neighborhood of the cell71,93.”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [99]
In the citing paper
“Several studies inferred the cell cycle phase of individual cells from single-cell RNA-seq data30,35,97,99, relying on transcriptional signatures of discrete phases from earlier bulk profiling experiments146.”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [99]
In the citing paper
“single-cell profiles provide a near-continuous sampling and show high conservation across cell types and species30,97,99”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,018
Tackling the Many Facets of Glioblastoma Heterogeneity
Tirosh, I., & Suvà, M. L. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.02.005 · Cited by 74
Self-citationCraig, M., Jenner, A. L., Namgung, B., Lee, L. P., & Goldman, A. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00356 · Cited by 74
Jalali, M., Hosseini, I. I., AbdElFatah, T., Montermini, L., Wachsmann‐Hogiu, S., Rak, J. W., & Mahshid, S. (2020) · Lab on a Chip · doi:10.1039/d0lc00957a · Cited by 74
Proteogenomics of glioblastoma associates molecular patterns with survival
Arad, G., Ofek, P., Yeini, E., Mardamshina, M., Danilevsky, A., Shomron, N., Grossman, R., Satchi‐Fainaro, R., & Geiger, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108787 · Cited by 78
Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors
Cui, Y., Li, C., Zhen-huan, J., Zhang, S., Li, Q., Liu, X., Zhou, Y., Li, R., Wei, L., Li, L., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab102 · Cited by 77
CCR2 deficiency alters activation of microglia subsets in traumatic brain injury
Somebang, K., Rudolph, J. D., Imhof, I., Li, L., Niemi, E. C., Shigenaga, J. K., Tran, H., Gill, T. M., Lo, I., Zabel, B. A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109727 · Cited by 77
Al‐Dalahmah, O., Argenziano, M., Kannan, A., Mahajan, A., Furnari, J. L., Paryani, F., Boyett, D. M., Save, A., Humala, N., Khan, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38186-1 · Cited by 75
Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment
Song, Q., Ruiz, J., Xing, F., Lo, H., Craddock, L., Pullikuth, A., Miller, L. D., Soike, M. H., O’Neill, S. S., Watabe, K., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05124-2 · Cited by 74
From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research
Rauner, G., Gupta, P. B., & Kuperwasser, C. (2025) · Nature Methods · doi:10.1038/s41592-025-02769-1 · Cited by 82
Application of single-cell genomics in cancer: promise and challenges
Wills, Q. F., & Mead, A. J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv235 · Cited by 77
Measuring intratumor heterogeneity by network entropy using RNA-seq data
Park, Y., Lim, S., Nam, J., & Kim, S. (2016) · Scientific Reports · doi:10.1038/srep37767 · Cited by 77
GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma
Moreno, M., Pedrosa, L., Paré, L., Pineda, E., Bejarano, L., Martínez, J., Balasubramaniyan, V., Ezhilarasan, R., Kallarackal, N., Kim, S.-H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.083 · Cited by 74
The Human Cell AtlasPreprint
Regev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C. O., Birney, E., Bodenmiller, B., Campbell, P. J., Carninci, P., Clatworthy, M. R., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/121202 · Cited by 86
Self-citationHigh-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastomaPreprint
Johnston, M. J. G., Nikolić, A., Ninkovic, N., Guilhamon, P., Cavalli, F. M. G., Seaman, S., Zemp, F. J., Lee, J., Abdelkareem, A. O., Ellestad, K. I., et al. (2019) · Genome Research · doi:10.1101/gr.246520.118 · Cited by 68
Single‐cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis
Ellsworth, D. L., Blackburn, H. L., Shriver, C. D., Rabizadeh, S., Soon‐Shiong, P., & Ellsworth, R. E. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0145-6 · Cited by 73
Turcan, Ş., & Cahill, D. P. (2018) · Seminars in Neurology · doi:10.1055/s-0037-1620238 · Cited by 73
Self-citationAdult Human Glioblastomas Harbor Radial Glia-like Cells
Wang, R., Sharma, R., Shen, X., Laughney, A. M., Funato, K., Clark, P. J., Shpokayte, M., Morgenstern, P. F., Navare, M., Xu, Y., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.01.007 · Cited by 72
Metabolic heterogeneity and adaptability in brain tumors
Badr, C. E., Silver, D. J., Siebzehnrübl, F. A., & Deleyrolle, L. P. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03569-w · Cited by 77
Zhang, S., Liu, Z., Wu, D., Chen, L., & Xie, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.596318 · Cited by 74
Tyler, M. P. H., & Tirosh, I. (2021) · Nature Communications · doi:10.1038/s41467-021-22800-1 · Cited by 77
Self-citationComba, A., Faisal, S. M., Varela, M. L., Hollon, T. C., Al‐Holou, W. N., Umemura, Y., Núñez, F. J., Motsch, S., Castro, M. G., & Lowenstein, P. R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.703764 · Cited by 79
Sundar, S. J., Shakya, S., Barnett, A., Wallace, L. C., Jeon, H.-M., Sloan, A. E., Recinos, V. R., & Hubert, C. G. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101251 · Cited by 74
Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing
Li, X., Shen, Y., Zhang, L., Guo, X., & Wu, J. H. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188720 · Cited by 73
A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness
Antonica, F., Santomaso, L., Pernici, D., Petrucci, L., Aiello, G., Cutarelli, A., Conti, L., Romanel, A., Miele, E., Tebaldi, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32448-0 · Cited by 78
Zhao, C., Zhu, X., Tan, J., Mei, C., Cai, X., & Kong, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116113 · Cited by 84
Harwood, D. S. L., Pedersen, V., Bager, N. S., Schmidt, A. Y., Stannius, T. O., Areškevičiūtė, A., Josefsen, K. E., Nørøxe, D. S., Scheie, D., Rostalski, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52167-y · Cited by 80
Intratumoral Heterogeneity in a Trp53 -Null Mouse Model of Human Breast Cancer
Zhang, M., Tsimelzon, A. I., Chang, C.-H., Fan, C., Wolff, A., Perou, C. M., Hilsenbeck, S. G., & Rosen, J. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1101 · Cited by 76
El-Habr, E. A., Dubois, L. G., Burel‐Vandenbos, F., Bogeas, A., Lipecka, J., Turchi, L., Lejeune, F., Coehlo, P. L. C., Yamaki, T., Wittmann, B. M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1659-5 · Cited by 79
Valid Post-clustering Differential Analysis for Single-Cell RNA-Seq
Zhang, J. M., Kamath, G. M., & Tse, D. N. (2019) · Cell Systems · doi:10.1016/j.cels.2019.07.012 · Cited by 72
Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
Muzumdar, M. D., Dorans, K. J., Chung, K. M., Robbins, R., Tammela, T., Gocheva, V., Li, C. M.-C., & Jacks, T. (2016) · Nature Communications · doi:10.1038/ncomms12685 · Cited by 72
Regulatory network changes between cell lines and their tissues of origin
Lopes‐Ramos, C. M., Paulson, J. N., Chen, C.-Y., Kuijjer, M. L., Fagny, M., Platig, J., Sonawane, A. R., DeMeo, D. L., Quackenbush, J. F., & Glass, K. (2017) · BMC Genomics · doi:10.1186/s12864-017-4111-x · Cited by 71
scCancer: a package for automated processing of single-cell RNA-seq data in cancer
Guo, W., Wang, D., Wang, S., Shan, Y., Liu, C., & Gu, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa127 · Cited by 70
Liu, K., Jiang, L., Shi, Y., Liu, B., He, Y., Shen, Q., Jiang, X., Nie, Z., Pu, J., Yang, C., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00969-2 · Cited by 73
Wang, T., Shi, J., Li, L., Zhou, X., Zhang, H., Zhang, X., Wang, Y., Liu, L., & Sheng, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840811 · Cited by 73
Assessment and prediction of glioblastoma therapy response: challenges and opportunities
Qi, D., Li, J., Quarles, C. C., Fonkem, E., & Wu, E. (2022) · Brain · doi:10.1093/brain/awac450 · Cited by 71
Monocyte-neutrophil entanglement in glioblastoma
Friedmann‐Morvinski, D., & Hambardzumyan, D. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163451 · Cited by 71
Transitioning single-cell genomics into the clinic
Lim, J. W. Y., Chin, V. T., Fairfax, K. A., Moutinho, C., Suan, D., Ji, H. P., & Powell, J. E. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00613-w · Cited by 74
Hou, A. J., Shih, R. M., Uy, B. R., Shafer, A. M., Chang, Z. L., Comin-Anduix, B., Güemes, M., Galić, Z., Phyu, S. M., Okada, H., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae126 · Cited by 81
Mitra, A., Mukherjee, U. K., Harding, T., Jang, J. S., Stessman, H. A. F., Li, Y., Abyzov, A. S., Jen, J., Kumar, S. K., Rajkumar, S. V., et al. (2015) · Leukemia · doi:10.1038/leu.2015.361 · Cited by 71
Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq
Gerber, T., Willscher, E., Loeffler‐Wirth, H., Hopp, L., Schadendorf, D., Schartl, M., Anderegg, U., Camp, J. G., Treutlein, B., Binder, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13666 · Cited by 76
MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer
Godlewski, J. A., Ferrer-Luna, R., Rooj, A. K., Mineo, M., Ricklefs, F. L., Takeda, Y. S., Nowicki, M. O., Salińska, E., Nakano, I., Lee, H., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.04.024 · Cited by 72
Dissecting human gliomas by single-cell RNA sequencing
Tirosh, I., & Suvà, M. L. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox126 · Cited by 72
Self-citationZhou, J., Du, X., Chen, X., Wang, J., Zhou, N., Wu, D., & Xu, B. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b12368 · Cited by 70
Multiclonal tumor origin: Evidence and implications
Parsons, B. L. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.05.001 · Cited by 79
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivityPreprint
Zanca, C., Villa, G. R., Benítez, J. A., Thorne, A. H., Koga, T., D’Antonio, M., Ikegami, S., Ma, J., Boyer, A. D., Banisadr, A., et al. (2017) · Genes & Development · doi:10.1101/gad.300079.117 · Cited by 73
Bernstock, J. D., Mooney, J. H., Ilyas, A., Chagoya, G., Estévez-Ordoñez, D., Ibrahim, A. G. A., & Nakano, I. (2019) · Journal of neurosurgery · doi:10.3171/2019.5.jns19364 · Cited by 75
Biological and Medical Importance of Cellular Heterogeneity Deciphered by Single-Cell RNA Sequencing
Gupta, R. K., & Kuźnicki, J. (2020) · Cells · doi:10.3390/cells9081751 · Cited by 74
Single-cell RNA-seq reveals different subsets of non-specific cytotoxic cells in teleost.
Niu, J., Huang, Y., Liu, X.-C., Zhang, Z., Tang, J., Wang, B., Lu, Y.-S., Cai, J., & Jian, J. (2020) · Genomics · doi:10.1016/j.ygeno.2020.09.031 · Cited by 70
The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
Mattei, V., Santilli, F., Martellucci, S., Monache, S. D., Fabrizi, J., Colapietro, A., Angelucci, A., & Festuccia, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083863 · Cited by 74
Computational immunogenomic approaches to predict response to cancer immunotherapies
Addala, V., Newell, F., Pearson, J. V., Redwood, A., Robinson, B. W. S., Creaney, J., & Waddell, N. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00830-6 · Cited by 79
Wang, B., Reville, P. K., Yassouf, M. Y., Jelloul, F. Z., Ly, C. P., Desai, P. N., Wang, Z., Borges, P., Veletić, I., Dasdemir, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45916-6 · Cited by 76
Cholinergic neuronal activity promotes diffuse midline glioma growth through muscarinic signaling
Drexler, R., Drinnenberg, A., Gavish, A., Yalçın, B., Shamardani, K., Rogers, A. E., Mancusi, R. A., Trivedi, V., Taylor, K. R., Kim, Y. S., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.031 · Cited by 82
Asymmetric Cell Division in T Lymphocyte Fate Diversification
Arsenio, J., Metz, P. J., & Chang, J. T. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.09.004 · Cited by 74
The Evolving Role of Molecular Markers in the Diagnosis and Management of Diffuse Glioma
Huse, J. T., & Aldape, K. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0831 · Cited by 69
Apoptosis in the fetal testis eliminates developmentally defective germ cell clones
Nguyen, D. H., Soygur, B., Peng, S.-P., Malki, S., Hu, G., & Laird, D. J. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00603-8 · Cited by 70
Applying multi‐omics toward tumor microbiome research
Zhang, N., Kandalai, S., Zhou, X., Hossain, F., & Zheng, Q. (2023) · iMeta · doi:10.1002/imt2.73 · Cited by 70
Zhang, N., Zhang, H., Liu, Z., Dai, Z., Wu, W., Zhou, R., Li, S., Wang, Z., Liang, X., Wen, J., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13409 · Cited by 71
Bosco, N., Goldberg, A., Zhao, X., Mays, J. C., Cheng, P., Johnson, A. F., Bianchi, J. J., Toscani, C., Tommaso, E. D., Katsnelson, L., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.029 · Cited by 71
Lucas, C. G., Mirchia, K., Seo, K., Najem, H., Chen, W., Zakimi, N., Foster, K. J., Eaton, C. D., Cady, M. A., Choudhury, A., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01747-1 · Cited by 72
CAR-T cell therapy for the treatment of adult high-grade gliomas
Park, S., Maus, M. V., & Choi, B. D. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00753-0 · Cited by 81
Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions
Tang, J., Karbhari, N., & Campian, J. L. (2025) · Cells · doi:10.3390/cells14070494 · Cited by 84
Attacking the supply wagons to starve cancer cells to death
Selwan, E. M., Finicle, B. T., Kim, S. M., & Edinger, A. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12121 · Cited by 73
Guerrero, P. A., Tchaicha, J. H., Chen, Z., Morales, J. E., McCarty, N., Wang, Q., Sulman, E. P., Fuller, G. N., Lang, F. F., Rao, G., et al. (2017) · Oncogene · doi:10.1038/onc.2017.248 · Cited by 70
NF-κB, Mesenchymal Differentiation and Glioblastoma
Yamini, B. (2018) · Cells · doi:10.3390/cells7090125 · Cited by 71
Glioblastoma multiforme: novel therapeutic targets
Muir, M. T., Gopakumar, S., Traylor, J. I., Lee, S., & Rao, G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1762568 · Cited by 71
Genetic Architectures and Cell-of-Origin in Glioblastoma
Kim, H. J., Park, J. W., & Lee, J. H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615400 · Cited by 69
Electrotherapies for Glioblastoma
Jenkins, E. P. W., Finch, A., Gerigk, M., Triantis, I. F., Watts, C., & Malliaras, G. G. (2021) · Advanced Science · doi:10.1002/advs.202100978 · Cited by 70
Wang, X., Liu, C., Chen, J., Chen, L., Ren, X., Hou, M., Cui, X., Jiang, Y., Liu, E., Zong, Y., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00445-8 · Cited by 69
Whole-genome doubling drives oncogenic loss of chromatin segregation
Lambuta, R. A., Nanni, L., Liu, Y., Díaz-Miyar, J., Iyer, A., Tavernari, D., Katanayeva, N., Ciriello, G., & Oricchio, E. (2023) · Nature · doi:10.1038/s41586-023-05794-2 · Cited by 74
Single-Cell RNA Sequencing: Technological Progress and Biomedical Application in Cancer Research
Xu, C., Zheng, Y., & Xu, K. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00777-0 · Cited by 79
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma
Spitzer, A., Gritsch, S., Nomura, M., Jucht, A., Fortin, J., Raviram, R., Weisman, H. R., Gonzalez Castro, L. N., Druck, N., Chanoch-Myers, R., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.03.008 · Cited by 69
Self-citationImplications of mitogen‐activated protein kinase signaling in glioma
Pandey, V., Bhaskara, V. K., & Babu, P. P. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23687 · Cited by 69
Reinartz, R., Wang, S., Kebir, S., Silver, D. J., Wieland, A., Zheng, T., Kupper, M. D., Rauschenbach, L., Fimmers, R., Shepherd, T. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2089 · Cited by 68
Using Large Datasets to Understand Nanotechnology
Paunovska, K., Loughrey, D., Sago, C. D., Langer, R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201902798 · Cited by 69
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma
Ammer, L.-M., Vollmann‐Zwerenz, A., Ruf, V., Wetzel, C. H., Riemenschneider, M. J., Albert, N. L., Beckhove, P., & Hau, P. (2020) · Cancers · doi:10.3390/cancers12102973 · Cited by 75
FastProject: a tool for low-dimensional analysis of single-cell RNA-Seq data
DeTomaso, D., & Yosef, N. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1176-5 · Cited by 58
Suphavilai, C., Chia, S., Sharma, A., Tu, L., Da Silva, R. P., Mongia, A., DasGupta, R., & Nagarajan, N. (2021) · Genome Medicine · doi:10.1186/s13073-021-01000-y · Cited by 58
The challenges associated with molecular targeted therapies for glioblastoma
Jue, T. R., & McDonald, K. L. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2080-6 · Cited by 68
Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells
Bayin, N. S., Frenster, J. D., Sen, R., Si, S., Modrek, A. S., Galifianakis, N., Dolgalev, I., Ortenzi, V., Illa-Bochaca, I., Khahera, A. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18117 · Cited by 67
Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology
Valdés‐Mora, F., Handler, K., Law, A. M. K., Salomon, R., Oakes, S. R., Ormandy, C. J., & Gallego‐Ortega, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02582 · Cited by 69
Wang, P., Guo, Q., Hao, Y., Liu, Q., Gao, Y., Zhi, H., Li, X., Shang, S., Guo, S., Zhang, Y., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1017 · Cited by 68
CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway
Fukasawa, K., Kadota, T., Horie, T., Tokumura, K., Terada, R., Kitaguchi, Y., Park, G., Ochiai, S., Iwahashi, S., Okayama, Y., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01745-1 · Cited by 65
Extracellular vesicles: The key for precision medicine in glioblastoma
Bene, M. D., Osti, D., Faletti, S., Beznoussenko, G. V., DiMeco, F., & Pelicci, G. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab229 · Cited by 72
Prakadan, S. M., Alvarez-Breckenridge, C. A., Markson, S. C., Kim, A. E., Klein, R. H., Nayyar, N., Navia, A. W., Kuter, B. M., Kolb, K. E., Bihun, I. V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25860-5 · Cited by 66
Self-citationCancer biology deciphered by single-cell transcriptomic sequencing
Li, Y., Jin, J., & Bai, F. (2021) · Protein & Cell · doi:10.1007/s13238-021-00868-1 · Cited by 67
Garcia-Diaz, C., Pöysti, A., Mereu, E., Clements, M., Brooks, L. J., Gálvez‐Cancino, F., Castillo, S. P., Tang, W., Beattie, G., Courtot, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112472 · Cited by 71
Intricate relationship between cancer stemness, metastasis, and drug resistance
Dakal, T. C., Bhushan, R., Xu, C., Gadi, B. R., Cameotra, S. S., Yadav, V., Maciaczyk, J., Schmidt‐Wolf, I. G. H., Kumar, A., & Sharma, A. (2024) · MedComm · doi:10.1002/mco2.710 · Cited by 71
Emerging strategies to investigate the biology of early cancer
Zhou, R., Tang, X., & Wang, Y. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00754-y · Cited by 72
Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity
Akl, C. F., Andersen, B. M., Li, Z., Giovannoni, F., Diebold, M., Sanmarco, L. M., Kilian, M., Fehrenbacher, L., Pernin, F., Rone, J. M., et al. (2025) · The Journal of Immunology · doi:10.1038/s41586-025-08997-x · Cited by 78
Ets Factors Regulate Neural Stem Cell Depletion and Gliogenesis in Ras Pathway Glioma
Breunig, J. J., Levy, R., Antonuk, C. D., Molina, J., Dutra‐Clarke, M., Park, H., Akhtar, A. A., Kim, G. B., Town, T., Hu, X., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.012 · Cited by 70
Cook, P. J., Thomas, R., Kannan, R., León, E., Drilon, A. E. D. C., Rosenblum, M. K., Scaltriti, M., Benezra, R., & Ventura, A. (2017) · Nature Communications · doi:10.1038/ncomms15987 · Cited by 67
Harnessing Tumor Evolution to Circumvent Resistance
McNamara, K. L., & Curtis, C. N. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.05.007 · Cited by 70
Hu, Q., & Greene, C. S. (2018) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789813279827_0033 · Cited by 68
Canella, A., Welker, A. M., Yoo, J. Y., Xu, J., Abas, F. S., Kesanakurti, D., Nagarajan, P., Beattie, C. E., Sulman, E. P., Liu, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3151 · Cited by 66
Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence
Kan, T., Zhang, S., Zhou, S., Ya, Z., Zhao, Y., Gao, Y.-H., Zhang, T., Gao, F., Wang, X., Zhao, L., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02139-z · Cited by 67
Chow, L. K.-Y., Chung, D. L., Tao, L., Chan, K. F., Tung, S. Y., Ngan, R. K., Ng, W. T., Lee, A. W. M., Yau, C. C., Kwong, D. L., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104357 · Cited by 71
Single-Cell Genomics: Approaches and Utility in Immunology
Neu, K. E., Tang, Q., Wilson, P. C., & Khan, A. A. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.12.001 · Cited by 73
MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer
Godlewski, J., Lenart, J., & Salinska, E. (2019) · Non-Coding RNA · doi:10.3390/ncrna5010020 · Cited by 52
Cell lysis via acoustically oscillating sharp edges
Wang, Z., Huang, P., Chen, C., Bachman, H., Zhao, S., Yang, S., & Huang, T. J. (2019) · Lab on a Chip · doi:10.1039/c9lc00498j · Cited by 67
Jansen, R. W., van Amstel, P., Martens, R. M., Kooi, I. E., Wesseling, P., de Langen, A. J., Menke-Van der Houven van Oordt, C. W., Jansen, B. H. E., Moll, A. C., Dorsman, J. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24893 · Cited by 63
Metadata
- Authors
- Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., Louis, D. N., Rozenblatt-Rosen, O., Suvà, M. L., Regev, A., & Bernstein, B. E.
- Affiliations
- Broad Institute (US)
- Harvard University (US)
- Broad Institute of Harvard and Massachusetts Institute of Techonology (MIT), Cambridge, MA 02142, USA.
- Corresponding author
- Patel, Anoop P.
- Tirosh, Itay
- Suvà, Mario L.
- Regev, Aviv
- Bernstein, Bradley E.
- ORCID
- Venue
- Science
- Published
- 2014-06-20
- Volume
- 344
- Issue
- 6190
- Pages
- 1396-1401
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4123637
- OpenAlex
- W1792532087
- Cited by
- 5,063
- References
- 47
- Citations by year
- 2026: 437 · 2025: 505 · 2024: 545 · 2023: 514 · 2022: 501 · 2021: 538 · 2020: 521 · 2019: 376 · 2018: 352 · 2017: 306 · 2016: 251 · 2015: 167 · 2014: 43
- FWCI
- 104.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Human Genome Research Institute (U54HG006991)
- National Cancer Institute (U24CA180922, P50CA165962)
- National Institute of Neurological Disorders and Stroke (R01NS032677, R25NS065743)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- glioblastoma, intratumoral heterogeneity, tumor heterogeneity, cancer stemness, transcriptional programs, oncogenic signaling, hypoxia, immune response, glioblastoma subtypes, prognostic factors, single-cell transcriptomics
- MeSH terms
- Brain Neoplasms, Glioblastoma, Humans, Prognosis, RNA, Messenger, Genetic Variation, Sequence Analysis, RNA, Gene Expression Profiling, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
